Company News
Aurobindo Pharma Holds 39th Annual General Meeting
Aurobindo Pharma held its 39th AGM on August 27, 2026, transacting all agenda items including financial statement adoption.
Shareholders confirmed an interim dividend of ₹4 per equity share for FY 202
